| | Class 2 Device Recall intelerad IntelePACS software |  |
| Date Initiated by Firm | September 10, 2026 |
| Date Posted | November 04, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-0357-2027 |
| Recall Event ID |
99971 |
| 510(K)Number | K192176 |
| Product Classification |
System, image processing, radiological - Product Code LLZ
|
| Product | intelerad IntelePACS software |
| Code Information |
HIBCC:B228INTELEPACS0/Affected versions: PACS-4-3-4-R20
PACS-4-9-1-R80
PACS-4-12-1-R81 through R90
PACS-4-14-1-R46 through R137
PACS-4-16-1-R50 through R137
PACS-4-17-1-R23 through R117
PACS-4-18-1-R31 through R91
PACS-5-1-1-R17 through R102
PACS-5-2-1-R36 through R93
PACS-5-3-1-R26 through R128
PACS-5-4-1-R15 through R101
PACS-5-5-1-R7 through R89
PACS-5-6-1-R12 through R81
PACS-5-7-1-R2 through R61
PACS-5-8-1-R2 through R42
PACS-5-9-1-R8 through R19 |
| FEI Number |
3003768392
|
Recalling Firm/ Manufacturer |
INTELERAD MEDICAL SYSTEMS INCORPORATED
800, Boul. de Maisonneuve Est
14th floor
Montreal
Canada
|
Manufacturer Reason for Recall | A cybersecurity vulnerability has been identified in the software that could allow a malicious user to take over an administrator session, delete or modify image or study data, or lock legitimate users out of the system. Additionally, a software issue has been identified that may result in the unintended deletion of image data from an external archive integration. |
FDA Determined Cause 2 | Software Design Change |
| Action | On September 15, 2026 Intelerad, (a GE HealthCare Company) issued a Urgent Medical Device Correction notification to affected consignees via: email. Intelerad ask consignees to take the following actions:
1. Pending corrections by Intelerad, you can continue to use your system by continuing to follow your organization's standard cybersecurity and access control practices until the corrective update is implemented.
2. Please ensure all potential users in your facility are made aware of this safety notification and the recommended actions.
3. Please retain this document for your records.
4. Please complete and return the attached acknowledgement form electronically via FMI 88101 Digital Response Form or email, or print, fill out manually, scan, and email to
Recall.88101@gehealthcare.com. |
| Quantity in Commerce | 560 software platforms |
| Distribution | US: AL FL CO MI CA TX CT AZ NJ IL NC SC MO NH WA KY WY DC NV IN PA AK OR AR KS TN MN MD IA WI HI NY OH VA WV NM GA LA NE UT WA
OUS: Australia , Canada, Ireland, New Zealand, South Africa, United Kingdom |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = LLZ
|
|
|
|